IDH2 mutations change the splicing effects of mutated SRSF2 and lead to more profound ASEs than single mutations alone, as well as lethal myelodysplasia with proliferative characteristics in vivo and enhanced tumor self-renewal. The gene discussed is IDH2; the disease is neoplasm.